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Abstract
The Hepatitis E virus (HEV) is widespread throughout the world. The purpose of this study was to evaluate the time-related change of
antibody levels against Hepatitis E in primary school children. In this cross sectional study, the samples of 515 students were examined
at two times. The mean age of the students was 7(6-13) years. The seroprevalences of anti-HEV were 1.7% and 2.1% at the ﬁrst and
second visits respectively. There was no statistically signiﬁcant differences between anti-HEV seropositivity and the parents’ education
and employment status (p >0.05). This serosurvey shows that there is not a high prevalence of enterically transmitted viral hepatitis in
Ankara, Turkey, which is a situation similar to developed countries.
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Introduction
Hepatitis E virus (HEV) infection is widespread throughout
the world. The epidemiology of HEV is very similar to that
of hepatitis A virus, which is also transmitted through the
faecal––oral route; however, it is serologically different.
HEV was ﬁrst deﬁned in 1983 and is known to be the
cause of non-A non-B hepatitis transmitted via the enteric
route. It is the most important cause of acute hepatitis in
many developing countries, especially when associated with
contaminated water [1]. HEV is the causative agent of both
water-borne epidemics and sporadic cases of viral hepatitis
in tropical and subtropical countries with inadequate sanita-
tion and low socioeconomic conditions [2–4]. An increased
population density and refugee situations also intensify the
problem.
HEV is a hepatotrophic virus consisting of spherical parti-
cles with a single-stranded RNA genome and no envelope. It
has spine-like projections on the surface similar to the Nor-
walk virus, and is similar to Calici virus and Alpha virus on
classiﬁcation [5]. It has a very wide-range clinical spectrum.
Especially in children, fulminating hepatitis can occur. After
an incubation period averaging 40 days and a prodromal
phase of 1–10 days, patients typically present with symptoms
of nausea, vomiting, abdominal pain and icterus [6]. HEV
infection does not appear to cause signiﬁcant morbidity in
most children and adults, although it represents a serious
health problem in pregnant women [4].
The HEV seroprevalence was found to be 0–18.8% in
studies conducted worldwide in different groups consisting
of persons aged 20 years or less [1,7–9]. The highest attack
rate for HEV-related clinical disease is seen in young- to
middle-aged adults in the 15–40-year-old age group. The
attack rate is markedly higher in pregnant women and then
varies in the range 17–40% in endemic areas [2]. A study
from ﬁve different regions in Turkey found anti-HEV sero-
positivity to be 2.3% in individuals aged under 26 years
[10]. Another study found the rate to be 12.5% in children
aged younger than 15 years [4]. A study of various child-
hood age groups in Istanbul found the highest seropreva-
lence to be 4.8% in children aged 6 months to 2 years
[11].
The fatality rate is usually 0.1–2.7% for HEV infections in
endemic areas, but can increase to 20% in the second and
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third trimesters in pregnant women, and the incidence of ful-
minant hepatic failure in these women can be up to 32% [2].
It is not considered that lifelong immunity can develop
against HEV. There are data showing that the IgG level
developing as a result of infection becomes negative in 52%
of those positive in the fourth month and the mean duration
of positivity is 2 years, whereas it falls below the protective
level after 5 years [3,12,13]. It is not possible to calculate
the incidence at a speciﬁc time-point because the seroposi-
tivity changes and the time to change is unknown [4]. Analy-
sis of the natural immunity level is both required and
important with respect to preventive measures, whereas
seroepidemiological studies are currently needed to identify
those sensitive to the infection.
The present study aimed to evaluate the time-related
change of antibody levels against HEV in children in Ankara.
Materials and Methods
Design and population
The present study was carried out at a primary school in
a semi-rural area of Ankara. The school was visited twice
in November 2003 and January 2005 to collect data. In
November 2003, there were 840 students aged 6–14 years.
In July 2004, 92 of these students had graduated and 76 of
them had left the school for other reasons. Consequently,
the study population consisted of 672 students at
school grades 1–7. A total of 515 students (76.6%) were
accessed for various reasons (family permission, insufﬁcient
serum).
All the analyses (for the years 2003 and 2005) were per-
formed using the data obtained from these 515 students.
Because the duration of the study period was 13 months
(November 2003 to January 2005), the change in seropreva-
lence was accepted as a ‘yearly change’.
We obtained written consent from the Province National
Education Directorate, Gazi University Medical Faculty Local
Ethic Committee (dated 21 March 2005, number 45) as well
as from the parents of each student. A survey form was sent
to all of the families that agreed to participate.
Samples
Blood samples consisting of 3–4 mL of venous blood were
drawn at both time points into plastic vacutainer tubes
(Plastic BD Vacutainer SST II Plus serum separation tube
without clot activating gel; BD Vacutainer Systems, Plym-
outh, UK), usually from the median cubital vein of the left
arm using a vacutainer needle (BD Vacutainer Passive
Shielding Blood Collection Needle) and holder (BD Vacu-
tainer Pronto Quick Release Holder). The serum was sepa-
rated by centrifugation of the blood samples at 1620 g
for 15 min in the same evening and the serum samples
were labelled and kept until the day of analysis in 1.5-mL
capped Eppendorf microcentrifuge tubes (Sigma-Aldrich
Chemie GmbH, Munich, Germany) at )80C (Deep Free-
zer, Heto, Holten, Denmark); all samples were studied
between February and April 2006. A commercially available
diagnostic anti-HEV ELISA kit (Human anti-HEV ELISA; Dia
Pro, Milan, Italy) was used to detect anti-HEV antibodies in
the serum samples. The assay, a third-generation ELISA for
the qualitative determination of IgG antibodies to HEV in
human serum, was performed according to manufacturer’s
instructions.
Statistical analysis
The analysis of data was performed with the SPSS 10.0 statisti-
cal software package (SPSS Inc, Chicago, IL, USA). Fisher’s
exact test, the McNemar test and chi-square tests were used
to compare groups for counted variables.
Results
A total of 515 students were studied. The study group con-
sisted of 52.7% male and 47.3% female students with a mean
age of 9.6 ± 0.1 years. The mothers of the students were
primary school graduates (73.0%) and housewives (95.8%).
The fathers were primary school graduates (48.4%) and
workers (43.7%). Of the families, 76.0% had health insurance.
The mean size of the children’s houses and the number of
rooms in the house were 84.5 ± 0.9 m2 and 3.0 ± 0.1,
respectively.
The distribution of the hepatitis E serology by year is
shown in Table 1. There was no statistically signiﬁcant differ-
ence among the years (2003–2005) regarding hepatitis E
seropositivity (p = 0.804).
TABLE 1. Distribution of the hepatitis E serology by year
among school children in Ankara
2003
2005
Total
Seronegative Seropositive
n %a n %a
Seronegative 497 96.5 9 1.7 506
Seropositive 7 1.4 2 0.4 9
Total 504 97.9 11 2.1 515
pb 0.804
aTotal percentage.
bMcNemar test.
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Table 2 presents the distribution of the hepatitis E serol-
ogy of the students in November 2003 and January 2005 by
sex and age. In November 2003, 1.7% of the students were
found to be anti-HEV seropositive. There was no statistically
signiﬁcant difference between the sexes with respect to
hepatitis E seropositivity (p = 0.181). We found 2.1% of
the students to be anti-HEV seropositive in January 2005.
There was no statistically signiﬁcant difference between the
sexes regarding hepatitis E serology (p = 0.763). Seven of
the children seropositive in 2003 became negative 1 year
later, whereas two were still seropositive. Among the chil-
dren who were seronegative in 2003, nine were found to be
positive 1 year later.
The distribution of the cases by age, grade, sex and years
of seropositivity is presented in Table 3. There was no statis-
tically signiﬁcant difference between anti-HEV seropositivity
and the education and employment status of the parents
(p >0.05) (Table 4).
Discussion
Although the present study appears to be a cross-sectional
study, it has a longitudinal component to determine a 1-year
change in hepatitis E seroprevalence among 6–13-year-old
school children.
We used a commercially available diagnostic ELISA kit to
detect anti-HEV IgG antibodies in the serum samples of the
students. The kit is Food and Drug Administration approved,
its speciﬁcity is >99.5%, and its diagnostic sensitivity is 100%.
False positivity is 1% in normal populations [4]. The kit has
been used for population-based screening of blood units [14].
HEV epidemiology varies from country to country. HEV
causes epidemic and/or endemic infections in developing
countries with infrastructure and hygiene problems, and
mostly manifests in sporadic cases in developed countries
[4]. The area where the study was conducted is a semi-rural
area with a sewage and water network. Sanitation of
TABLE 2. Distribution of the hepatitis E seropositive school
children in Ankara at two time points, by sex and age
n = 515
Hepatitis E serology
2003 2005
n %a n %a
Sex
Male 7 2.6 5 1.8
Female 2 0.8 6 2.5
pb >0.05 – –
Agec
6 – – 1 2.8
7 – – – –
8 – – – –
9 2 2.4 5 5.9
10 7 10.8 2 3.1
11 – – 2 2.7
12 – – 1 1.5
13 – – – –
pb >0.05
Total 9 1.7 11 2.1
aPercentage of seropositives.
bChi-square test.
cThe ages of the children in 2003 were taken into consideration.
TABLE 3. Distribution of the cases by age, grade, sex and
years of seropositivity
Case no. Age Grade Sex Years of seropositivity
1 10 3 M 2003–2005
2 10 5 M 2003
3 10 5 M 2003
4 10 5 M 2003
5 9 4 M 2003
6 9 4 F 2003
7 10 5 M 2003
8 10 5 F 2003–2005
9 10 4 M 2003
10 9 2 M 2005
11 9 2 F 2005
12 9 2 F 2005
13 11 3 F 2005
14 9 2 M 2005
15 9 2 M 2005
16 6 1 M 2005
17 12 4 F 2005
18 11 3 F 2005
TABLE 4. Distribution of HEV serology by the education
and employment status of the parents of school children in
Ankara
Characteristics
2003 2005
Seropositive Seropositive
n %a n %a
Mother’s education status
Illiterate or barely literate 1 1.6 – –
Primary school graduate 7 1.9 8 2.1
Secondary school or
higher graduate
1 1.3 3 3.9
pb >0.05 >0.05
Mother’s employment status
Housewife 9 1.8 11 2.2
Employed and/or retired – – – –
pb >0.05 >0.05
Father’s education status
Illiterate or barely literate – – – –
Primary school graduate 4 1.6 4 1.7
Secondary school graduate 3 2.2 5 3.8
High school or higher
graduate
2 1.7 2 1.7
pb >0.05 >0.05
Father’s employment status
Worker 4 1.8 4 1.8
Civil servant 1 1.1 3 3.4
Self-employed – – – –
Retired 4 2.2 4 2.1
pb >0.05 >0.05
aRow percentage.
bChi-square test.
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network water is performed with automatic chlorination in
this area, although the effect of sanitation on HEV serology
was not investigated in this study.
One study from 11 countries has reported that the HEV
infection rate increases with age in many countries [1],
whereas another study reported a high attack rate in paedi-
atric cases [4]. In the present study, we found the HEV sero-
positivity rate to be 1.7% in 2003 and 2.1% in 2005. A study
from Istanbul of children aged 6 months to 16 years found
the seropositivity rate to be 2.1% in the 5–9-year-old age
group and 0.3% in the 10–16-year-old age group [11].
A study from Konya (in the Central Anatolian Region of
Turkey), similar to Ankara, reported the seropositivity rate
as 10.0% in the 5–9-year-old age group and 21% in the 10–
15-year-old age group [7]. The seropositivity was 1.4% in
children aged 1–15 years, with the highest seropositivity rate
of 1.75% in children aged 11–15 years in a study of children
presenting at a university hospital in northern Turkey [15]. A
study from the south coast of Turkey (Antalya) found an
anti-HEV IgG prevalence of 1.6% in children of school age
[16]. These studies from various parts of Turkey indicate a
variability in HEV seropositivity in the <1–15-year-old age
group. However, these studies did not investigate the change
in serology during a period more than 1 year [7,11,15,16].
The investigation of serology changes may also reveal the
burden of disease as a result of HEV. The present study is
the ﬁrst such investigation in Turkey.
The socioeconomic and environmental factors that could
inﬂuence HEV seropositivity have not been adequately inves-
tigated in these studies. Only one study [7] has found the
HEV seropositivity rate to be the highest (25.0%) in the
group with low income. We did not ﬁnd a statistically signiﬁ-
cant difference in our study regarding HEV seropositivity and
the education and employment status of the parents
(p >0.05).
The HEV seropositivity rates vary between developing and
developed countries. A study from Mongolia of children and
adolescents aged <1–20 years found anti-HEV IgG in 0.7% of
cases with the ages reported at 1 month and 1, 3, 8 and
15 years [17]. A study of employees of the Gesellschaft fu¨r
Technische Zusammenarbeit (a German technical aid organi-
zation) and their family members found that no children or
adolescents aged <20 years were positive for HEV, although
some children had grown up in areas endemic for HEV [8].
A study from Taiwan of children aged 3–6 years found HEV
seropositivity in 3.0% of children living in urban areas, 3.7%
of children living in rural areas and 3.9% of children living in
the aboriginal region [18]. A study in people who migrated
from Turkey to Italy found no HEV seropositivity in any child
aged 0–10 years, whereas the highest seropositivity was in
the group of those aged >30 years [20.4%] [9]. A Brazilian
study also found no seropositivity in any child aged
0–10 years [19].
The studies cited above are generally from countries
with populations of a socioeconomic status similar to that
of Turkey. The percentage of the population having access
to clean water is 75% in Brasil, 75% in Mongolia and 88%
in Turkey [20]. However, there are differences in HEV
seropositivity. The present study also found changes
within 1 year. The two children who were found to be
seropositive during the ﬁrst study were still found to
be seropositive in 2005.
In the present study, the variation of hepatitis E
seropositivity was investigated for a rather short, 13-month
period. Therefore, the limitations of the study and their pos-
sible effects on the results should be considered.
In conclusion, the present serosurvey does not reveal a
high prevalence of enterically transmitted viral hepatitis.
Although the results obtained in the study indicate that the
HEV prevalence in children of the study region was lower
than that in endemic areas and similar to that in developed
countries, this does not mean that there is no need for
some form of health education intervention. National or
local health authorities should organize follow-up pro-
grammes, with the contribution of stakeholders, such as
the Ministry of Education, with respect to the health educa-
tion of children, which should teach, for example, the need
for hand washing. We tend to support the hypothesis that,
in hepatitis E, a signiﬁcant loss of speciﬁc antibodies takes
place over time. Further investigations are needed to estab-
lish the real situation of HEV infection among children in
other regions of the country and also to determine
whether one individual can be reinfected repeatedly after
the immune response has declined, as well as when this will
happen.
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